Patents by Inventor Alem Jusic
Alem Jusic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230047777Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: October 31, 2022Publication date: February 16, 2023Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 11517318Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: February 8, 2021Date of Patent: December 6, 2022Assignee: Miracor Medical SAInventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Publication number: 20210236136Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: February 8, 2021Publication date: August 5, 2021Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 10912570Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: February 21, 2019Date of Patent: February 9, 2021Assignee: Miracor Medical SAInventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Publication number: 20190175190Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: February 21, 2019Publication date: June 13, 2019Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 10238394Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: June 19, 2017Date of Patent: March 26, 2019Assignee: Miracor Medical SAInventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Publication number: 20180064445Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: June 19, 2017Publication date: March 8, 2018Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 9681875Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: August 25, 2016Date of Patent: June 20, 2017Assignee: Miracor Medical Systems Co.Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Publication number: 20160361068Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: August 25, 2016Publication date: December 15, 2016Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 9433381Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: December 23, 2011Date of Patent: September 6, 2016Assignee: Miracor Medical Systems GmbHInventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Publication number: 20130165736Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: ApplicationFiled: December 23, 2011Publication date: June 27, 2013Applicant: MIRACOR MEDICAL SYSTEMS GMBHInventors: Werner Mohl, Gregor Neumayr, Alem Jusic
-
Patent number: 8177704Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.Type: GrantFiled: December 22, 2011Date of Patent: May 15, 2012Assignee: Miracor Medical Systems GmbHInventors: Werner Mohl, Gregor Neumayr, Alem Jusic